Detection and Radiological Imaging of SLN


Breast Cancer Sentinel Node Sentinel Node Biopsy Gamma Probe Sentinel Lymph Node Mapping 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albertini, JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, Berman CG, Jared K, Messina J, Lyman G, Glass F, Fenske N, Reintgen DS (1996) Intraoperative radio-lymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 223:217–224CrossRefPubMedGoogle Scholar
  2. Borgstein PJ (1998) SLN biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186:275–283Google Scholar
  3. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F (1998) Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 351:793–796CrossRefPubMedGoogle Scholar
  4. Cox CE, Pendas S, Cos JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS (1998) Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227:645–651CrossRefPubMedGoogle Scholar
  5. Domagala W, Lasota J, Bartkowiak J, Weber K, Osborn M (1990 a) Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am J Pathol 136(1):219–227PubMedGoogle Scholar
  6. Domagala W, Lasota J, Dukowicz A, Markiewski M, Striker G, Weber K, Osbon M (1990 b) Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas. Am J Pathol 137(6):1299–304PubMedGoogle Scholar
  7. Domagala W, Wozniak L, Lasota J, Weber K, Osborn M (1990 c) Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas. Am J Pathol 137(5):1059–1064PubMedGoogle Scholar
  8. Dupont EL, Salud CZ, Peltz ES, Nguyen K, Whitehead GF, Ku NN, Reintgen DS, Cox CE (2001) Clinical relevance of internal mammary node mapping as a guide to radiation therapy. Am J Surg 182(4):321–324CrossRefPubMedGoogle Scholar
  9. Edreira MM, Colombo LL, Perez JH, Sajaroff EO, Castiglia SG de (2001) In vivo evaluation of three different 99mTc-labelled radiopharmaceuticals for sentinel lymph node identification. Nucl Med Commun 22(5):499–504CrossRefPubMedGoogle Scholar
  10. Eubank WB, Mankoff DA, Takasugi J, Vesselle H, Eary JF, Shanley TJ, Gralow JR, Charlop A, Ellis GK, Lindsley KL, Austin-Seymour MM, Funkhouser CP, Livingston RB (2001) 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol 1; 19(15):3516–3523PubMedGoogle Scholar
  11. Glass EC (2001) Nuclear medicine in the detection of the sentinel node. Ann Surg Oncol 8[Suppl]:5S–8SPubMedGoogle Scholar
  12. Gommans GM, Dongen A van, Schors TG van der, Gommans E, Visser JF, Clarijs WW, Ward JW de, Bos J van de, Boer RO (2001) Further optimization of 99mTc nanocoll sentinel node localization in carcinoma of the breast by improved labeling. Eur J Nucl Med 28:1450–1455CrossRefPubMedGoogle Scholar
  13. Kim R, Osaki A, Kojima J, Toge T (2001) Significance of lymphoscintigraphic mapping with Tc-99m human serum albumin and tin colloid in sentinel lymph node biopsy in breast cancer. Int J Oncol 19:991–996PubMedGoogle Scholar
  14. Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK, Laughlin EH, Alex JC (1995) Minimal access surgery for staging of malignant melanoma. Arch Surg 130(6):654–658; 659–660PubMedGoogle Scholar
  15. Leong SPL, Steinmetz I, Habib FA, McMillan A, Gans JZ, Allen RE Jr, Morita ET, el-Kadi M, Epstein HD, Kashani-Sabet M, Sagebiel RW (1997) Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 132:666–673PubMedGoogle Scholar
  16. Macmillan RD, Barbera D, Hadjiminas DJ, Rampaul RS Lee AH, Pinder SE, Ellis IO, Blamey RW, Geraghty JG (2001) Sentinel node biopsy for breast cancer may have little to offer four-node-samplers: results of a prospective comparison study. Eur J Cancer 37(9):1076–1080CrossRefPubMedGoogle Scholar
  17. Paganelli G, De Cicco C, Cremonesi M, Prisco G, Calza P, Luini A, Zucali P, Veronesi U (1998) Optimised sentinel node scintigraphy in breast cancer. Q J Nucl Med 42:49–53PubMedGoogle Scholar
  18. Paramo JC, Summerall J, Wilson C, Cabral A, Willis I, Wodnicki H, Poppiti R, Mesko TW (2001) Intraoperative sentinel lymph node mapping in patients with colon cancer. Am J Surg 182(1):40–43CrossRefPubMedGoogle Scholar
  19. Rauschecker H, Clarke M, Gatzemeier W, Recht A (2001) Systemic therapy for treating loco regional recurrence in women with breast cancer (Cochrane Review). Cochrane Database Syst Rev 4 CD 002195Google Scholar
  20. Saha S, Nora D, Wong JH, Weise D (2000) Sentinel lymph node mapping in colorectal cancer — a review. Surg Clin North Am 80(6):1811–1819CrossRefPubMedGoogle Scholar
  21. Schauer A, Marx D, Schauer M, Binder C, Kuhn W, Meden H. Breast preserving surgery decision making. Anticancer Res 18(3C):2107–2137Google Scholar
  22. Siddon RL, Clin LM, Zimmermann RE, Mendel JB, Kaplan WD (1982) Utilisation of parasternal lymphoscintigraphy in radiation therapy of breast carcinoma. Int J Radiat Oncol Biol Phys 8(6):1059–1063PubMedGoogle Scholar
  23. Simmons RM, Brennan MB, Christos P, Sckolnick M, Osborn M (2001) Recurrence rates in patients with central or retroareolar breast cancers treated with mastectomy or lumpectomy. Am J Surg 182(4):325–329CrossRefPubMedGoogle Scholar
  24. Sun SS, Tsai SC, Ho YJ, Kao CH (2001) Detection of cervical lymph node metastases in nasopharyngeal carcinomas: comparison between technetium 99mmethoxyisobutylisonitrile single photon emission computed tomography and computed tomography. Anticancer Res 21(2B):1307–1310PubMedGoogle Scholar
  25. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P (1997) Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864–1867CrossRefPubMedGoogle Scholar
  26. Wascher RA, Bostik PJ, Huynh KT, Turner R, Qik, Giuliano AE, Hoon DS (2001) Detection of MAGE-A3 in breast cancer patients sentinel lymph-nodes. Br J Cancer 85(9):1340–1346CrossRefPubMedGoogle Scholar
  27. Waters GS, Geisinger KR, Garske DD, Loggie BW, Levine EA (2000) Sentinel lymph node mapping for carcinoma of the colon: a pilot study. Am Surg 66(10):943–945; 945–946PubMedGoogle Scholar
  28. Wiese DA, Saha S, Badin J, Ng PS, Gauthier J, Ahsan A, Yu L (2000) Pathologic evaluation of sentinel lymph-nodes in colorectal carcinoma. Arch Pathol Lab Med 124(12): 1759–1763PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Personalised recommendations